Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs

How long should I stop GLP-1 medications before surgery?

Reviewed by the glpzoom Editorial Team against primary clinical sources — FDA labeling, peer-reviewed trials, and specialty-society guidelines.
Content current as of June 2026; updated when guidance or availability changes.
Per American Society of Anesthesiologists (ASA) 2024 guidance: hold once-weekly GLP-1 agonists (Wegovy, Ozempic, Zepbound, Mounjaro) for at least 1 week before elective surgery requiring general anesthesia. The concern is delayed gastric emptying — even after 8-12 hour pre-operative fasting, GLP-1 patients may retain stomach contents, increasing aspiration risk during anesthesia induction. For liraglutide (Saxenda, Victoza, daily injection), hold the day of surgery. For emergent surgery where GLP-1 can't be held, anesthesia teams use rapid sequence induction and gastric ultrasound to manage risk. Tell your surgeon AND anesthesiologist about your GLP-1 use even if not asked. Restart after surgery once you're tolerating oral intake without nausea.

Where to start

Licensed US telehealth services that handle this. We may earn a commission when you sign up. See disclosure.

  • Ro logo

    Ro

    from $145/mo
    • Best for insured patients
    • Best for clinical oversight

    Ro Body — branded GLP-1 weight care program

  • Hims logo

    Hims

    from $199/mo
    • Best for cash-pay
    • Best for speed

    Hims Weight Loss — compounded GLP-1 from $199/mo

  • Noom Med logo

    Noom Med

    from $179/mo
    • Best for coaching
    • Best for maintenance

    Noom Med — GLP-1 + behavioral psychology coaching

Drugs referenced

Related questions

  • Can I take Wegovy on a plane?

    Yes. TSA allows in carry-on (never checked). Original packaging with prescription label. Insulated bag + ice for flights >4h. Physician letter for international travel.

  • What are the most common Wegovy side effects?

    The most common Wegovy side effects are gastrointestinal: nausea (40-44% of trial patients), diarrhea (30%), vomiting (24%), and constipation (24%). These typically peak during dose escalation in the first 4-8 weeks and improve as the body adapts. Less common but serious risks include gallbladder problems, pancreatitis, kidney strain (especially if dehydrate

We may earn a commission when you click links to partners. Affiliate disclosure.